| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1011238744 |
| P356 | DOI | 10.1245/S10434-012-2297-3 |
| P932 | PMC publication ID | 4158737 |
| P698 | PubMed publication ID | 22446898 |
| P5875 | ResearchGate publication ID | 221975620 |
| P2093 | author name string | Michelle C Janelsins | |
| Luke J Peppone | |||
| Kristin A Skinner | |||
| Aaron S Rickles | |||
| Michael R Insalaco | |||
| P2860 | cites work | Cancer statistics, 2010 | Q27860525 |
| A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer | Q28297827 | ||
| Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91 | Q28372839 | ||
| Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study | Q31001849 | ||
| Vitamin D regulates the phenotype of human breast cancer cells. | Q33272824 | ||
| Effectiveness and safety of vitamin D in relation to bone health. | Q33310980 | ||
| No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year | Q33638583 | ||
| Vitamin D and prevention of breast cancer: pooled analysis | Q33845175 | ||
| A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis | Q33899901 | ||
| Vitamin D deficiency and insufficiency among patients with prostate cancer | Q33927888 | ||
| Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women's Health Initiative. | Q33954508 | ||
| Possible role of serum 25-hydroxyvitamin D in black-white health disparities in the United States | Q34024496 | ||
| Musculoskeletal adverse events associated with adjuvant aromatase inhibitors. | Q34143532 | ||
| Intestinal calcium absorption: Molecular vitamin D mediated mechanisms | Q34169596 | ||
| Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial | Q34175166 | ||
| Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. | Q34246571 | ||
| Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer | Q34279148 | ||
| Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors | Q34383136 | ||
| Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer | Q34577228 | ||
| Intakes of calcium and vitamin D and breast cancer risk in women | Q34579813 | ||
| Vitamin D and muscle function | Q34625407 | ||
| Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. | Q34659177 | ||
| Diagnosis and treatment of vitamin D deficiency. | Q34724756 | ||
| Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial | Q34732123 | ||
| The effect of various vitamin D supplementation regimens in breast cancer patients | Q34893987 | ||
| Gene-expression signatures in breast cancer | Q34948421 | ||
| Meta-analysis of vitamin D, calcium and the prevention of breast cancer | Q35009220 | ||
| Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer | Q35089964 | ||
| Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells | Q35195902 | ||
| Incidence and mortality of hip fractures in the United States | Q35541830 | ||
| Racial disparities in breast cancer survival: an analysis by age and stage | Q35618805 | ||
| Serum 25-hydroxyvitamin D levels in early and advanced breast cancer | Q35770459 | ||
| Vitamin D insufficiency in North America | Q36020310 | ||
| Vitamin D, calcium, and breast cancer risk: a review | Q36559995 | ||
| A high incidence of vertebral fracture in women with breast cancer | Q36617488 | ||
| Skeletal complications of breast cancer therapies | Q36633831 | ||
| Multivitamin-multimineral supplements: who uses them? | Q36701918 | ||
| Aromatase inhibitor-associated arthralgia syndrome | Q36763312 | ||
| Blood biomarkers of vitamin D status | Q37133639 | ||
| High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy | Q37171282 | ||
| Assessing the vitamin D status of the US population | Q37238637 | ||
| Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer | Q37275627 | ||
| Regulation of vitamin D homeostasis: implications for the immune system | Q37290258 | ||
| Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials | Q37421108 | ||
| An intergenerational approach in the promotion of balance and strength for fall prevention - a mini-review | Q37780920 | ||
| In vivo precision of the GE Lunar iDXA densitometer for the measurement of total-body, lumbar spine, and femoral bone mineral density in adults | Q38482659 | ||
| Skeletal sites for osteoporosis diagnosis: the 2005 ISCD Official Positions | Q40321452 | ||
| Autocrine metabolism of vitamin D in normal and malignant breast tissue | Q40427845 | ||
| The crippling consequences of fractures and their impact on quality of life | Q41597014 | ||
| Postmenopausal survivors of breast cancer at risk for osteoporosis: nutritional intake and body size | Q42170735 | ||
| Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry | Q42510173 | ||
| A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases | Q43240682 | ||
| Prevalence and correlates of vitamin D deficiency in US adults | Q43950527 | ||
| Effects on bone mineral density of calcium and vitamin D supplementation in elderly women with vitamin D deficiency | Q44483037 | ||
| Hip fractures in institutionalized elderly people: incidence rates and excess mortality | Q44612757 | ||
| Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). | Q44797217 | ||
| Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis | Q46042022 | ||
| High-dose oral vitamin D3 supplementation in the elderly. | Q46186830 | ||
| Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study | Q46328350 | ||
| Estimates of optimal vitamin D status | Q46388606 | ||
| Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population | Q46505311 | ||
| Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude | Q46695423 | ||
| Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. | Q50758473 | ||
| Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. | Q50790541 | ||
| Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Breast Cancer | Q56087735 | ||
| Redefining vitamin D insufficiency | Q56087787 | ||
| Hypovitaminosis D in Medical Inpatients | Q57414040 | ||
| Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study | Q57419291 | ||
| Vitamin D Status Predicts Physical Performance and Its Decline in Older Persons | Q60298072 | ||
| Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer | Q60595420 | ||
| Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III | Q64128190 | ||
| Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial | Q77833207 | ||
| Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study | Q84602644 | ||
| P433 | issue | 8 | |
| P921 | main subject | vitamin D | Q175621 |
| breast cancer | Q128581 | ||
| P304 | page(s) | 2590-2599 | |
| P577 | publication date | 2012-03-24 | |
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels | |
| P478 | volume | 19 |
| Q36162969 | 25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma |
| Q37623331 | A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium |
| Q92850174 | A multicenter case control study of association of vitamin D with breast cancer among women in Karachi, Pakistan |
| Q36759573 | A survey on the relationship between serum 25-hydroxy vitamin D level and tumor characteristics in patients with breast cancer |
| Q46158151 | Association of Vitamin D3 Level with Breast Cancer Risk and Prognosis in African-American and Hispanic Women |
| Q38150669 | Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis |
| Q55360424 | Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort. |
| Q26766205 | Breast cancer survival among young women: a review of the role of modifiable lifestyle factors |
| Q55664332 | Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies. |
| Q34575016 | Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies |
| Q38678296 | Identification of tumor-autonomous and indirect effects of vitamin D action that inhibit breast cancer growth and tumor progression |
| Q98289831 | Inhibition of HAS2 and hyaluronic acid production by 1,25-Dihydroxyvitamin D3 in breast cancer |
| Q27693209 | Modeling vitamin D actions in triple negative/basal-like breast cancer |
| Q41463405 | Phytotherapy and Nutritional Supplements on Breast Cancer |
| Q36974513 | Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project |
| Q26774591 | Risk factors and biomarkers of life-threatening cancers |
| Q35980745 | Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study |
| Q35269540 | Serum 25-hydroxy vitamin D and survival in advanced colorectal cancer: a retrospective analysis |
| Q49378717 | Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer. |
| Q99570666 | Serum Vitamin Levels and Their Relationships with Other Biomarkers in Korean Breast Cancer Patients |
| Q35803741 | The effect of pre-diagnostic vitamin D supplementation on cancer survival in women: a cohort study within the UK Clinical Practice Research Datalink |
| Q33749897 | The impact of vitamin D in breast cancer: genomics, pathways, metabolism. |
| Q33688792 | The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm |
| Q36753868 | Tumor Autonomous Effects of Vitamin D Deficiency Promote Breast Cancer Metastasis. |
| Q47426563 | Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer |
| Q26766256 | Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological Evidence |
| Q92571848 | Vitamin D and breast cancer: A systematic review and meta-analysis of observational studies |
| Q21195200 | Vitamin D and the mammary gland: a review on its role in normal development and breast cancer |
| Q35603114 | Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness |
| Q92300411 | Vitamin D intake, blood vitamin D levels, and the risk of breast cancer: a dose-response meta-analysis of observational studies |
Search more.